-
-
-
-
-
-
-
iRhythm expects 2025 revenue to exceed $740 million guidance
-
-
-
-
-
-
-
iRhythm Technologies (IRTC) Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
iRhythm® Technologies Announces Changes to Its Board of Directors
-
-
-
-
-
-
-
Digital Transformation of Healthcare: CEO’s of ONEM, HCAT, DOCRF, IRTC, Discuss Telemedicine, Big Data, and Diagnostics
-
-
-
-
1,178,437 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

